BlueOrange Asset Management November Results

Our weighted average return in November was -0.96%. Since 2015, we have generated a net return of +38.73%.

In terms of investment strategy performance, our weighted average net returns for November were (a) +0.15% for conservative strategies, (b) -0.09% for balanced strategies, and (c) -2.11% for aggressive strategies.

Markets continued to be extremely volatile in November. The S&P 500 index traded all over the place, giving up -3.83% in the third week of the month, before jumping +4.71% the very next week. By month end, the S&P 500 had gained +2%. Emerging market stocks (+5.07%) finally managed to rally on the back of lower US bond yields, and US investment grade bonds ended the month +0.64%.

Politically speaking, the US mid-term elections played out as expected with the Republicans gaining seats in the Senate, and the Democrats claiming a majority in the House of Representatives. A Democrat majority in the House will now be able to curtail Republican attempts to expand fiscal stimulus to ingratiate themselves to voters before the Presidential elections in 2020. Party politics aside, the overwhelming political issue in the world today remains US-China trade tensions and the continued uncertainty as to whether a deal will be able to be reached or not. Uncertainty abounds in Europe as well due to Italy’s budget issues and Brexit.

As such, we are in an environment where companies are recording record earnings, but their future ability to generate profits are being heavily discounted due to political uncertainty. This is evident in the price action that we are seeing in certain sectors of the market.

For old school portfolio managers with an equity mandate, volatile markets mean moving assets into defensive sectors such as consumer staples and utilities. As a result, these sectors have performed very well since the summer, whereas growth sectors such as information technology and biotech have sold off heavily. Conceptually, this makes a lot of sense, but in actuality, this is purest form of trying to ‘time markets’ and intuitively speaks to why most portfolio managers fail to beat their benchmark indices in the long-run. How so? Because most often this means chasing returns and ignoring fundamental valuation principles that are the foundation of long term outperformance.

For example, let us take a look at a classic consumer staple stock: Proctor & Gamble. P&G has a number of different brands that households use every day, from skin care (‘Olay’), to laundry detergent (‘Tide’), to diapers (‘Pampers’), to dish soap (‘Fairy’). The ‘every day’ use of these products is the critical component of why P&G is considered consumer staple company. P&G is great company, but it faces massive challenges on a daily basis to stay relevant to its consumers who are constantly tempted by new, upstart brands with product descriptions that say things like “small batch” or “artisanal”. P&G’s sales have been flat to negative over the past four years and they pay high multiples to acquire new brands (their last acquisition was done on a 5x price to sales valuation…). All of this would be fine if not for the fact that P&G shares trade at a steep 23 times next year’s earnings, with no intrinsic growth in sight.

Now, let us take a look at Apple. Apple makes the most successful and possibly most technologically advanced consumer product in history: the iPhone. With the exception of infants wearing ‘Pampers’, anyone with an iPhone spends considerably more time on this device on a daily basis than they do with every single possible combination of P&G products, and, from anecdotal evidence, even infants would rather use an iPhone than a diaper. However, since Apple became the first company to exceed 1 trillion in market capitalization this summer, Apple shares have lost around 30% from their highs – or 365 billion USD in valuation. This equates to 1.5x the current market capitalization of P&G. A practically unfathomable amount.

Although Apple’s sales have also slowed in the past couple of years, they remain astoundingly high. From a valuation perspective, after removing the net cash component from their market capitalization, Apple currently trades at a 10.72 next year’s earnings – which means that the market values every dollar in earnings that P&G generates as twice as valuable as a dollar earned by Apple. Yes, I understand that we are comparing apples to ‘tide pods’, but I welcome any and all arguments that attempt to justify this dynamic above and beyond short term price movement.

We have not owned Apple shares for quite some time. This was due to the fact that we saw more compelling growth opportunities or relative value elsewhere in the market. However, at these valuations, Apple is once again a screaming buy and we have initiated large positions in Apple over the past couple of weeks. By the way, the last two times Apple shares traded at a P/E multiple this low, they rallied over 130%... Overall, this sell off - although fraught with much near term negative price action and flat out stress - has given us the chance to buy back shares of companies that we deem to be the consumer staples of the future at significant discounts to where they had been trading for a long period of time. It is hard to be thankful when you are in the second month of negative returns, but this is a battle won with sound rationale and patience.

A year from now we will be talking with prospective clients that ‘knew’ that they should have been buying Apple shares ‘at the end of 2018’ but found some reason not to. They will say something to the effect of ‘yes, Apple @ 170, that was easy money’. We will smile and agree. Not because it was easy, but because we actually did it.

On behalf of our Client Portfolio Management team, I thank you for your continued trust and support!

Pauls Miklaševičs

FULL DISCLOSURE: Please note that the opinions expressed in this blog should in no way be considered as investment advice or a solicitation to buy or sell securities.

Important Legal Information

Nothing contained herein constitutes an offer, solicitation or recommendation regarding any investment product or service, or the offer to sell or the solicitation of an offer to buy any financial instrument; nor shall any such services be provided, or financial instruments be offered or sold, in any jurisdiction in which such an offer, solicitation, provision or sale would be unlawful. All content is subject to applicable statutes and regulations. Any potential investor should satisfy oneself that an investment in any product and/or service mentioned in this material is permissible under the rules and regulations of his or her domicile. This material is not directed to any person in any jurisdiction where (by reason of that person's nationality, residence or otherwise) the availability of the material is prohibited.

The information provided is for reference only and investors should determine for themselves whether a particular service or product is suitable and appropriate for their investment needs or should seek such professional advice for their particular situation. Please refer to offering documents for further information concerning specific products.

Certain statements contained herein may be statements of future expectations and other forward-looking statements that are based on current views and assumptions of AS BlueOrange Bank and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. In addition to statements which are forward-looking by reason of context, the words “may, will, should, expects, plans, intends, anticipates, believes, estimates, predicts, potential, or continue” and similar expressions identify forward-looking statements. BlueOrange assumes no obligation to update any forward-looking information contained herein.


Past performance is no guarantee of future results. Investing in the financial markets is subject to certain risks including market, interest-rate, issuer, credit, and inflation risk. Financial instruments may appreciate or depreciate in price owing to conditions, whether real or apparent, in a given market, economy or industry. The value of investments, and the income from them, can go down as well as up, and you may not recover the amount of your original investment. Where investments involve currency exposure, changes in rates of exchange may cause the value of the investment to go up or down. Any tax benefits referred to on this material are subject to change and their availability and value will depend on your individual circumstance.

No Reliance

Although BlueOrange has taken reasonable care to ensure that the information contained within this material is accurate, no representation or warranty (including liability towards third parties), expressed or implied, is made as to its accuracy, reliability or completeness by BlueOrange. Opinions and any other contents of the material are provided by BlueOrange for personal use and for tentative reference only. Nothing contained on this material constitutes investment, legal, tax or other advice and is not to be relied on in making an investment or other decision.

© 2018 AS BlueOrange Bank. All rights reserved.